title: Treatment of hypertension in renal transplant recipients.
abstract: OBJECTIVE
  Hypertension is very common in renal transplant recipients and is a significant risk factor for mortality from cardiovascular diseases and for development of graft dysfunction.
  
  
  RESULTS
  Recent guidelines for the treatment of hypertension (Joint National Committee on Prevention, Detection, and Treatment of High Blood Pressure VI Report and World Health Organization Guidelines) do not directly address post-transplant hypertension. Specific recommendations for the drug treatment of hypertension in renal allograft recipients have not been given in the Clinical Practice Guidelines of the American Society of Transplantation or those of the European Renal Association.
  
  
  CONCLUSIONS
  The present paper summarizes some important aspects of post-transplant hypertension and discusses potential treatment strategies aimed at reducing blood pressure and thus improving patient and allograft survival.
authors.affiliation: Department of Internal Medicine, Nephrology and Transplantology, Medical University of Gdansk, Gdansk, Poland. leszek.tylicki@wp.pl
authors.forename: Leszek
authors.initials: L
authors.lastname: Tylicki
authors.forename: Antje
authors.initials: A
authors.lastname: Habicht
authors.forename: Bruno
authors.initials: B
authors.lastname: Watschinger
authors.forename: Walter H
authors.initials: WH
authors.lastname: Hörl
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000209:etiology / Q000628:therapy*; D006977:Hypertension, Renal / Q000209:etiology / Q000628:therapy; D006978:Hypertension, Renovascular / Q000209:etiology / Q000628:therapy; D007166:Immunosuppressive Agents / Q000009:adverse effects; D016030:Kidney Transplantation / Q000009:adverse effects*; D009392:Nephrectomy; D012078:Renal Artery Obstruction / Q000209:etiology / Q000601:surgery
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D007166:Immunosuppressive Agents